+1.224.938.9523

HUMAN AMYLOID IMAGING CONFERENCE

The 15th edition of the HAI will be held in Miami, FL on January 11-13, 2023.

HAI 2023 POSTER SESSIONS


Click the “+” to open each module; tables can be sorted by clicking on each item of the header row (board number, poster title, authors and presenter, respectively).  Additionally, each table is searchable (use the search field located at the top right of each module).

Please note that we reserve the right to re-arrange the poster allocation.  

POSTER SESSIONS: 1A - Wednesday, January 11 - 9:45 - 10:30 am; 1B - Wednesday, January 11, 4:00 - 4:45 pm
Board #TitleAuthorsPresenterPresenter/Affiliation
1Effects of de-facing PET and MRI scans on clinical correlations analysesSchwarz | Kremers | Weigand | Prakaashana | Senjem | Lowe | Gunter | Kantarci | Vemuri | Petersen | Knopman | JackSchwarz, ChristopherChristopher Schwarz, Mayo Clinic, Rochester, MN, US
2Non-invasive quantification and SUVR validation of [18F]-florbetaben with total-body EXPLORER PETHoly | Alfaro | Fletcher | Bhattarai | Spencer | Cherry | DeCarli | FanHoly, EmilyEmily Holy, Department of Neurology, UC Davis Health, Davis, CA, US
3PET imaging probe development for aggregated alpha-synucleinGomperts | Liu | Bai | Xu | Rose | Celikag | Ndayisaba | Khurana | Bartels | WangGomperts, StephenStephen Gomperts, Department of Neurology, Massachusetts General Hospital, Boston, MA, US
4Cross-modality transformer for low-dose tau PET imagingJang | Lois | Becker | Thibault | Price | Johnson | El Fakhri | GongJang, Se-InSe-In Jang, Massachusetts General Hospital, Boston, MA, US
5Tau PET positivity reveals Alzheimer’s disease related fast cognitive declineIoannou | Bucci | Nordberg | ChiotisIoannou, KonstantinosKonstantinos Ioannou, Nordberg Translational Molecular Imaging Lab, Division of Clinical Geriatrics, Center for Alzheimer’s Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, SE
6Positive 18F-APN-1607 tau PET imaging findings in patients with Progressive Supranuclear Palsy-like extrapyramidal symptoms caused by TBK1 mutationsLiu | Lu | Sun | Li | Yen | Jang | Zuo | WangLiu, Feng-TaoFeng-Tao Liu, Department of Neurology & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, CN
7In vivo visualization of tau deposits in corticobasal syndrome by 18F-Florzolotau PETLiu | Lu | Li | Jiao | Chen | Yao | Liang | Ge | Li | Shen | Wu | Sun | Wu | Yen | Zuo | WangLiu, Feng-TaoFeng-Tao Liu, Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, CN
8Imaging neuroinflammation with astrocyte-PET and bio-fluid biomarkers in patients with cognitive impairmentChiotis | Jelic | Rodriguez-Vieitez | Savitscheva | Wall | Antoni | NordbergChiotis, KonstantinosKonstantinos Chiotis, Department NVS, Karolinska Institutet, Stockholm, SE
9[18] Flortaucipir PET and Diffusion Tensor Tractography Coregistration can Enhance Detection of Brain Changes Associated with Progressive Apraxia of SpeechGatto | Duffy | Utianski | Clark | Botha | Machulda | Lowe | Josephs | WhitwellGatto, Rodolfo G.Rodolfo G. Gatto, Division of Neurology, Mayo Clinic, Rochester, MN, US
10Towards a simplified flortaucipir-PET read method for assessing tau burdenTunali | Iaccarino | Ducker | Patel | DiFabbio | Kowaleski | Arora | Kim | Lu | Pontecorvo | ShcherbininTunali, IlkeIlke Tunali, Eli Lilly and Company, Indianapolis, IN, US
11Effects of different imaging acquisition time on SUVR and Centiloid scale values in flutemetamol PET scansKato | Iwata | Suzuki | Tsujimito | Nihashi | Sakurai | Kimura | Nakamura | Ikari | Niimi | Ishii | Senda | Ito | IwatsuboKato, TakashiTakashi Kato, National Center for Geriatrics and Gerontology, Obu, JP
12Digital clock drawing performance is associated with tau deposition measured with PET in preclinical Alzheimer’s diseaseFu | Rentz | Mayblyum | Thibault | Buckley | Das | Papp | Sperling | Penney | Davis | Johnson | PriceFu, Jessie Fang-LuJessie Fang-Lu Fu, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, US
13[18F]RO-948 Tau PET Retention and Correlation with Fluid Biomarkers in the Early AD ContinuumShekari | González Escalante | Milà-Alomà | Falcon | Niñerola-Baizán | Tonietto | Borroni | Klein | J. Ashton | K. Karikari | Lantero-Rodriguez | Snellman | Ortiz | Vanmechelen | Minguillón | Fauria | Perissinotti | Molinuevo | Zetterberg | Blennow | Grau-Rivera | Suárez-Calvet | Domingo GispertShekari, MahnazMahnaz Shekari, Barcelona?eta Brain Research Center (BBRC), Pasqual Maragall Foundation,, Barcelona, ES
14Regional tau predicts glucose hypometabolism in autosomal dominant Alzheimer’s disease: Findings from the Colombia-Boston (COLBOS) biomarker studyLangella | Kaplan | Baena | Londono | Munera | Vila-Castelar | Alvarez | Vidal | Properzi | Sanchez | Sperling | Johnson | Lopera | Hanseeuw | QuirozLangella, StephanieStephanie Langella, Massachusetts General Hospital / Harvard Medical School, Boston, MA, US
15Is tau PET a robust biomarker for chronic traumatic encephalopathy?Krishnadas | Doré | Lamb | Guzman | Ponsford | Hicks | Williams | Feizpour | Villemagne | RoweKrishnadas, NatashaNatasha Krishnadas, Florey Institute of Neurosciences & Mental Health, Melbourne, AU
16Centiloid scale measure of amyloid PET by CT of PET/CT equipmentMatsuda | Hanyu | KanekoMatsuda, HiroshiHiroshi Matsuda, Fukushima Medical University, Fukushima, JP
17Successful cognitive aging is associated with less brain atrophy and lower tau depositionPezzoli | Giorgio | Harrison | Martersteck | JagustPezzoli, StefaniaStefania Pezzoli, Helen Wills Neuroscience Institute, University of California, Berkeley, CA, US
18Subcortical flortaucipir PET and susceptibility analyses to differentiate progressive supranuclear palsy clinical variants and corticobasal syndromeSatoh | Arani | Schwarz | Senjem | Ali | Jack | Lowe | Josephs | WhitwellSatoh, RyotaRyota Satoh, Mayo Clinic, Rochester, MN, US
19Temporal associations of plasma and PET Alzheimer’s disease biomarkers using a non-linear mixed effects modelCogswell | Lundt | Therneau | Graff-Radford | Schwarz | Senjem | Gunter | Vemuri | Petersen | Jack JrCogswell, PetricePetrice Cogswell, Department of Radiology, Mayo Clinic, Rochester, MN, US
20Beta-amyloid accumulates at a faster rate in individuals with Down syndromeMcVea | DiFilippo | McLachlan | Murali | Zammit | Johnson | Betthauser | Stone | Tudorascu | Laymon | Klunk | Cohen | Handen | ChristianMcVea, AndrewAndrew McVea, University of Wisconsin - Madison, Madison, WI, US
21Cross-sectional PET Analyses in the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS)Cho | Mundada | Apostolova | Carrillo | Shankar | Amuiri | Zeltzer | Windon | Soleimani Meigooni | Tanner | Lawhn Heath | Aisen | Eloyan | Koeppe | Iaccarino | Dickerson | La Joie | RabinoviciCho, HannaHanna Cho, Memory and Aging Center, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, US
22Amyloid and tau pathology associated with different cognitive declines in cognitively normal older peopleChen | Juarez | Baker | Harrison | Landau | JagustChen, XiXi Chen, University of California, Berkeley, Berkeley, CA, US
23Future amyloid accumulation status affects the preservation of peripheral whole-blood gene co-expression networks at baseline in asymptomatic Alzheimer’s diseaseLuckett | Zielonka | Schaeverbeke | Adamczuk | Van Laere | Dupont | Cleynen | VandenbergheLuckett, EmmaEmma Luckett, Laboratory for Cognitive Neurology, KU Leuven, Leuven, BE
24Validation of [18f]florbetaben PET quantitation based on the analysis of 15 software pipelinesJovalekic | Roé-Vellvé | Koglin | Lagos Quintana | Nelson | Diemling | Lilja | Gómez González | Doré | Bourgeat | Whittington | Gunn | Stephens | BullichStephens, AndrewAndrew Stephens, Life Molecular Imaging, Berlin, DE
25Preprocessing 10,700 real-world amyloid-PET scans from the IDEAS study: the Good, the Bad and the UglyMejia Perez | Mundada | Blazhenets | Soleimani-Meigooni | Zeltzer | Cho | Ranasinghe | Windon | Yadollahikhales | Iaccarino | Carrillo | Gatsonis | March | Apgar | Siegel | Hilner | Whitmer | Rabinovici | La JoieMejia Perez, JhonyJhony Mejia Perez, Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, US
26Longitudinal tau-PET differs between progressive apraxia of speech subtypesTetzloff | Martin | Duffy | Clark | Utianski | Botha | Machulda | Schwarz | Senjem | Jack Jr. | Lowe | Josephs | WhitwellTetzloff, Katerina A.Katerina A. Tetzloff, Mayo Clinic Department of Neurology, Rochester, MN, US
27Magnitude of MK6240 off-target binding correlated with spill-in effects in target regionsMcVea | DiFilippo | McLachlan | Johnson | Betthauser | ChristianMcVea, AndrewAndrew McVea, University of Wisconsin - Madison, Madison, WI, US
28Dynamic amyloid PET: relationships to tau PET and cognition in Alzheimer’s diseaseRaman | Charniaux | Murchison | Fang | Tzabari | Liu | Morris | Chen | Joseph-Mathurin | Ponisio | Flores | Kennedy | Benzinger | Roberson | McConathyRaman, FabioFabio Raman, The University of Alabama at Birmingham, Department of Radiology, Birmingham, AL, US
29Spatial extent and intensity of Alzheimer-associated tau PET burden is greater in agrammatic than logopenic primary progressive aphasiaMartersteck | Sridhar | Coventry | Weintraub | Mesulam | RogalskiMartersteck, AdamAdam Martersteck, Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University, Chicago, IL, US
30Comparing PI2620 and Flortaucipir in Progressive Supranuclear Palsy SubjectsThomas | Blazhenets | La Joie | Rabinovici | Heuer | Jagust | Boxer | BakerThomas, WesleyWesley Thomas, University of California, Berkeley, Berkeley, CA, US
31Assessing a universal neocortical mask for Centiloid quantificationBourgeat | Dore | Rowe | Benzinger | Tosun | Goyal | LaMontagne | Jin | Weiner | Morris | Masters | Fripp | VillemagneBourgeat, PierrickPierrick Bourgeat, Australian eHealth Research Centre, CSIRO Health and Biosecurity, Herston, AU
32Relationships between Neuronal Hyperactivity, Stress Susceptibility, and Alzheimer’s Disease pathologySharp | Razlighi | OhOh, HwameeHwamee Oh, Carney Institute for Brain Science, Brown University, Providence, RI, US
33A/T/N, cognitive, health and lifestyle differences across white matter hyperintensities groups in aged 45-85 years adults: Results from the Wisconsin Registry for Alzheimer's Prevention (WRAP)Du | Burghy | Cody | Hermann | Jonaitis | Betthauser | Chin | Cadman | Rivera-Rivera | Peret | Johnson | Rowley | Pompa | Lose | Christian | Janelidze | Hansson | Johnson | Eisenmenger | KoscikDu, LianlianLianlian Du, Wisconsin Alzheimer’s Institute, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, US
34Medial temporal 18F-MK6240 levels are associated with global graph characteristics of functional connectivity from high-density EEG in the asymptomatic and prodromal stage of Alzheimer diseaseSpruyt | Reinartz | Meade | Khachatryan | Van Hulle | Van Laere | Dupont | VandenbergheSpruyt, LaureLaure Spruyt, Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, BE
35Longitudinal PET assessments of tau pathologies in progressive supranuclear palsy with 18F-florzolotau (PM-PBB3/APN-1607)Endo | Takado | Tagai | Matsuoka | Kokubo | Hirata | Kataoka | Oya | Matsumoto | Kurose | Ichihashi | Hatano | Saiki | Hirano | Nakano | Furukawa | Takeda | Isose | Imai | Yagi | Nishida | Yuasa | Ono | Seki | Takahata | Tokuda | Shinotoh | Shimada | Kawamura | Zhang | HiguchiEndo, HironobuHironobu Endo, Department of Functional Brain Imaging, Institute for Quantum Medial Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, JP
36Head-to-head comparison of tau PET tracers [18F]PI2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohortKlein | Marquié | Sotolongo-Grau | Roé-Vellvé | Bullich | Tartari | Sanabria | García-Sánchez | Borroni | Galli | Tonietto | Pérez-Martínez | Tárraga | Ruiz | Stephens | BoadaKlein, GregoryGregory Klein, Roche Pharma Research and Early Development, Basel, CH
POSTER SESSIONS: 2A - Thursday, January 12 - 10:45 - 11:30 am; 2B - Thursday, January 12, 4:00 - 4:45 pm
Board #TitleAuthorsPresenterPresenter/Affiliation
37Regional [F18]AV1451 uptake in progressive apraxia of speech with and without Alzheimer’s disease, dysexecutive, and logopenic variants of Alzheimer’s diseaseSwitzer | Corriveau-Lecavalier | Lowe | Jones | Ramanan | Machulda | Graff-Radford | Boeve | Knopman | Jack | Petersen | Josephs | Whitwell | BothaSwitzer, Aaron R Aaron Switzer, Mayo Clinic, Rochester, MN, US
38Estimation of Native Spatial Resolution in Clinical Positron Emission Tomography Imaging DataGalli | Tonietto | Klein | Holiga | Miho | KnopfGalli, ChristopherChristopher Galli, Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F.Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland, Basel, CH
39Neuroinflammation Co-Localizes with Tau in Early-Onset MCI patientsFinn | Appleton | Bradbury | Yu | Faridar | Beers | Appel | Fujita | Masdeu | PascualFinn, QuentinQuentin Finn, Nantz National Alzheimer Center, Houston Methodist Neurological and Research Institute, Houston, TX, US
40Lower locus coeruleus integrity identifies elevated entorhinal tau in low amyloid individuals and is associated with faster clinical progressionEngels-Domínguez | A. Koops | M. Riphagen | F. Smegal | Bueichekú | Becker | M. Kwong | M. Rentz | H. Salat | A. Sperling | A. Johnson | I. L. JacobsEngels-Domínguez, NinaNina Engels-Domínguez, Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, US
41Substantia nigra 18F-PI-2620 PET signal is associated with motor impairment in Lewy body diseaseWiner | Vossler | Young | Romero | Shahid | Abdelnour | Anders | Shen | Mormino | PostonWiner, JosephJoseph Winer, Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, US
42Sex differences in A? and tau vulnerability in preclinical Alzheimer’s diseaseOurry | St-Onge | Mohammediyan | Yakoub | Soucy | Poirier | Breitner | VilleneuveOurry, ValentinValentin Ourry, Department of Psychiatry, Faculty of Medicine, McGill University, Montréal, QC, CA
43Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET): Defining the future of Alzheimer's treatment, imaging and careWhitlow | March | Rabinovici | Rafii | Atri | Daffner | Edelmayer | Gatsonis | Lopez | Porsteinsson | Possin | Salloway | Sano | Snyder | Vukmir | Wilkins | Windon | CarrilloWhitlow, ChristopherChristopher Whitlow, American College of Radiology, Reston, VA, US
44Acquisition time corrections for SUVR analyses of [18F]-PI-2620Young | Vossler | Winer | Romero | Anders | Shen | Poston | Davidzon | MorminoYoung, ChristinaChristina Young, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, US
45Longitudinal accumulation of white matter lesions is associated with amyloidosis and brain atrophy, but not systemic vascular riskShirzadi | Schultz | Yau | Fitzpatrick | Levin | Joseph-Mathurin | Kantarci | Preboske | Jack Jr. | Farlow | Fagan | Hassenstab | Jucker | Morris | Xiong | Karch | Levey | Gordon | Schofield | Salloway | Perrin | McDade | Levin | Cruchaga | Allegri | Fox | Goate | Day | Koeppe | Noble | Chui | Berman | Mori | Sanchez-Valle | Lee | Rosa-Neto | Ruthirakuhan | Wu | Swardfager | Benzinger | Sohrabi | Martins | Schultz | Bateman | Johnson | Sperling | Greenberg | ChhatwalShirzadi, ZahraZahra Shirzadi, Massachusetts General Hospital, Brigham and women’s hospital, Harvard Medical School, Boston, MA, US
46SEX-ASSOCIATED DIFFERENCES IN CEREBROSPINAL FLUID AND PLASMA BIOMARKERS IN EARLY-ONSET ALZHEIMER’S DISEASENemes | Logan | Dage | Fagan | Hammers | Manchella | Eloyan | Kostadinova | Foroud | Zetterberg | Koeppe | Aisen | Carrillo | Rabinovici | Dickerson | ApostolovaNemes, SáraSára Nemes, Indiana University School of Medicine, Indiana, IN, US
47Correlations between Janssen Simoa plasma p217+tau and tau PET in participants screened for Janssen’s Au?onomy Ph2 anti-tau trial in early Alzheimer’s DiseaseSaad | Triana-Blatzer | Moughadam | Slemmon | Henley | KolbSaad, Ziad S.Ziad S. Saad, Neuroscience Biomarkers and Global Imaging, Janssen R&D, Johnson & Johnson, San Diego, CA, US
48Sleep apnea and poor sleep quality are linked to tau deposition in older women at higher risk for Alzheimer’sLui | Shepherd | Wang | Bernier | Bosompra | DeYoung | Malhotra | Sundermann | BanksLui, KittyKitty Lui, San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, US
49Machine Learning Based Tau Positivity Classification On Tau-PET Scans Considers Biological Variability And Can Aid In Decision MakingGebre | Rial | Raghavan | Sparrman | Wiste | Schwarz | Lowe | Graff-Radford | Knopman | Petersen | Schöll | Jack Jr | VemuriGebre, RobelKitty Lui, San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, US
50Impact of florbetaben acquisition timing on SUVR and centiloid valuesJohns | Kennedy | Young | Younes | Vossler | Poston | Davidzon | MorminoJohns, EmilyEmily Johns, Stanford University School of Medicine, Stanford, CA, US
51Postmortem In Vitro Binding of APN-1607 to PSP and HC Globus Pallidus HomogenatesTempest | Margolin | Paget | Campbell | NaviaTempest, PaulPaul Tempest, Aprinoia Theraputics, Cambridge, MA, US
52A CenTauR scale based on 18F-MK6240Dore | Bourgeat | Leuzy | Huang | Krishnadas | Feizpour | Fripp | Villemagne | RoweDore, VincentVincent Dore, Health and Biosecurity Flagship, The Australian eHealth Research Centre, CSIRO, Melbourne, AU
53Histone deacetylase tracer [11C]Martinostat behaves differently in amyloid versus synuclein rich regions in dementia with Lewy bodiesGoodheart | Yoo | Striar | Quan | Wey | Wang | GompertsGoodheart, AnnaAnna Goodheart, Department of Neurology, Massachusetts General Hospital, Boston, MA, US
54Tau accumulation across the Alzheimer's disease continuum: an 18F-MK6240 AIBL studyKrishnadas | Doré | Robertson | Ward | Fowler | Masters | Bourgeat | Fripp | Villemagne | RoweKrishnadas, NatashaNatasha Krishnadas, Florey Department of Neurosciences & Mental Health, The University of Melbourne, Melbourne, AU
55Multi-modal analysis of myelin and neurofilament light chain in individuals at risk for Alzheimer’s disease using MRI, PET, and CSF biomarker assessmentsYang | Dean III | Betthauser | Carlsson | Johnson | Blennow | Zetterberg | Alexander | BendlinYang, Kao LeeKao Lee Yang, Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, WI, US
56The gut microbiota metabolite trimethylamine n-oxide is associated with white matter degeneration on the Alzheimer’s disease continuumMoody | Heston | Zarbock | Blennow | Zetterberg | Rey | Ulland | BendlinMoody, JasonJason Moody, Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, Madison, WI, US
57In vivo measures of fibrillar beta-amyloid pathology limits cognitive plasticity in healthy aging: A multi-center intervention study.Bischof | Fellerhoff | Giehl | DrzezgaBischof, GerardGerard Bischof, University of Cologne, University Hospital of Cologne, Department of Nuclear Medicine, Multimodal Neuroimaging Group, Cologne, Germany, Cologne, DE
58One Year Longitudinal Change of Tau Accumulation on [18F]PI-2620 PET in Alzheimer SpectrumOh | Oh | Lee | Oh | Seo | Roh | Lee | KimOh, MinyoungMinyoung Oh, Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KR
59The role of vascular pathology in the association between amyloid-? and tau in cognitively unimpaired individualsCoomans | van Westen | Pichet Binette | Strandberg | Spotorno | Palmqvist | Stomrud | Ossenkoppele | HanssonCoomans, EmmaEmma Coomans, Radiology & Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, NL
60Dual biomarker amyloid PET for improved subtype and stage inferenceScott | Coath | Dickson | McQuaid | Cash | SchottScott, Catherine JCatherine J Scott, Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, GB
61Standardization of Tau PET using the CenTauR Scale: Preliminary findings from BioFINDER-2 using [18F]RO948 and [18F]Flortaucipirleuzy | Doré | Klein | Collins | Henscheid | Hostetler | Iaacarino | Karten | Kolb | Ossenkoppele | Pappas | Pontecorvo | Saad | Mathotaarachchi | Sivakuraman | Smith | Rowe | Villemagne | HanssonLeuzy, AntoineAntoine Leuzy, Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden, Malmö, SE
62Plasma GFAP and NFL are correlated with measures of global cognition in EOAD and EOnonADKostadinova | Hammers | Logan | Manchella | Nemes | Fagan | Foroud | Zetterberg | Kramer | Aisen | Carrillo | Rabinovici | Dickerson | Apostolova | DageKostadinova, Ralitsa V.Ralitsa V. Kostadinova, Indiana University School of Medicine, Indianapolis, IN, US
63Comparisons of plasma biomarkers with 18F-Florzolotau PET in AD continuum – a pilot studyHuang | Ing-Tsung | Lin | HuangHuang, Kuo-LunKuo-Lun Huang, Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, TW
65Shared variance between FDG metabolism and PiB tracer delivery is not predictive of cognitive decline in preclinical ADMayblyum | Shirzadi | Becker | Chhatwal | Farrell | Jacobs | Guehl | El Fakhri | Sperling | Price | Johnson | Schultz | HanseeuwMayblyum, DanielleDanielle Mayblyum, Massachusetts General Hospital, Boston, MA, US
64Validating Tau PET Staging Schemes in Relation to Cognitive OutcomesHammers | Lin | Logan | Risacher | Schwarz | ApostolovaHammers, DustinDustin Hammers, Indiana University School of Medicine, Department of Neurology, Indianapolis, IN, US
66Amyloid and tau PET are associated with plasma phosphorylated tau 181 and glial fibrillary acidic protein in a sample of heterogeneous dementia syndromesCousins | Phillips | Das | Fulop | Nasrallah | O'Brien | McMillan | Irwin | Massimo | Grossman | WolkPhillips, JeffreyJeffrey Phillips, University of Pennsylvania, Philadelphia, PA, US
67Combined and independent effects of hyperphosphorylation of tau on microglial activationRahmouni | Therriault | Tissot | L. Benedet | Ashton | Triana-Baltzer | Lussier | Servaes | Macedo | Stevenson | Stevenson | Kunach | Fernandez-Arias | Wang | Gauthier | Kolb | Karikari | Zetterberg | Blennow | Pascoal | Rosa-NetoRahmouni, NesrineNesrine Rahmouni, Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, Montreal, QC, CA
68Cognitive impairment is more closely associated with the regional extension of F18MK6240 tau-PET signal than with PET signal intensity or CSF tau measuresHanseeuw | Gerard | Malotaux | Colmant | Quenon | Ivanoiu | LhommelHanseeuw, BernardBernard Hanseeuw, Cliniques Universitaires Saint-Luc, Brussels, BE
69Disentangling spatial-temporal remote interaction between tau and Amyloid-? proteins in different stages of tau aggregationsHojjati | Feiz | Nayak | Shteingart | Ozoria | Fernández | Devanand | Luchsinger | Stern | RazlighiHojjati, Seyed HaniSeyed Hani Hojjati, Weill Cornell Medicine, New York, NY, US
70Predictors of Discordance Between Pre-PET Clinical Diagnosis and Amyloid-PET Results in the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) StudyTanner | La Joie | Hanna | Iaccarino | Allen | Siegel | Hillner | Whitmer | Gatsonis | Carrillo | RabinoviciTanner, JeremyJeremy Tanner, Memory and Aging Center, University of California San Francisco, San Francisco, CA, US
71Mid-life atherosclerotic cardiovascular disease risk score and late-life AT(N) measuresSaeed | Chang | Royse | Lopresti | Snitz | Villemagne | Reis | Lopez | CohenCohen, AnnAnn Cohen, University of Pittsburgh School of Medicine, Pittsburgh, PA, US
72A clinical diagnosis of Alzheimer’s disease and CSF-based tau positivity are both associated with lower locus coeruleus metabolismKoops | Dutta | Becker | Van Egroo | Riphagen | Prokopiou | Hanseeuw | Sperling | El Fakhri | Johnson | JacobsKoops, Elouise A.Elouise A. Koops, Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Boston, MA, US
POSTER SESSIONS: 3A - Friday, January 13, 9:15 - 10:00 am; 3B - Friday, January 13, 3:15 - 4:00 pm
Board #TitleAuthorsPresenterPresenter/Affiliation
73Motion and partial volume corrections in dynamic [18F]-MK6240 PET imagingTiss | Gong | Lois | Becker | Thibault | Guehl | Xia | Normandin | Ouyang | Johnson | El FakhriTiss, AmalAmal Tiss, Gordon Center for Medical Imaing, Department of Imaging, Massachusetts General Hospital, Boston, MA, US
75Comorbid medical conditions, anxiety, and amyloid-β pathology in cognitively unimpaired older adultsAbiose | Young | Winer | Deters | MorminoAbiose, OlamideOlamide Abiose, Stanford University School of Medicine Department of Neurology & Neurological Sciences, Stanford, CA, US
76Defining and characterizing neocortical tau resistance in preclinical Alzheimer’s diseaseBuckley | Klinger | Boyle | Coughlan | Hanseeuw | Yang | Amariglio | Rentz | Townsend | Farrell | Jacobs | Shirzadi | Yau | Price | Chhatwal | Schultz | Hohman | Donohue | Properzi | Johnson | SperlingBuckley, RachelRachel Buckley, Massachusetts General Hospital, Department of Neurology, Boston, MA, US
77Development and evaluation of image preprocessing pipelines for the Centiloid methodLuo | Minhas | Rubenstein | Situ | Royse | Ances | Christian | Cohen | Handen | Klunk | Tudorascu | Zamon | LaymonLuo, WeiquanWeiquan Luo, Department of Radiology, University of Pittsburgh, Pittsburgh, PA, US
78Cognitively estimated disease time: Associations with amyloid and tau burden in the Harvard Aging Brain StudyTownsend | Properzi | Betthauser | Klinger | Boyle | Coughlan | Hanseeuw | Yang | Amariglio | Farrell | Jacobs | Shirzadi | Yau | Price | Chhatwal | Rentz | Johnson | Sperling | Schultz | BuckleyTownsend, DianaDiana Townsend, Department of Neurology, Massachusetts General Hospital, Boston, MA, US
79Synergistic interaction between sex, amyloid and phosphorylated tau predicts the longitudinal progression of tau tanglesWang | Therriault | Servaes | Tissot | Fernandez Arias | Rahmouni | Macedo | Stevenson | Stevenson | Haeger | Hosseini | Nazneen | Rosa-NetoWang, Yi-TingYi-Ting Wang, McGill Centre for Studies in Aging, Montreal, QC, CA
80[18F]PI-2620 binding patterns in patients with suspected AD- and FTLD-tauopathiesBlazhenets | Soleimani-Meigooni | Thomas | Brendel | Vento | VandeVrede | Heuer | Ljubenkov | Rojas | Chen | Iaccarino | Mundada | Litvan | Grossman | Boeve | Pantelyat | Tartaglia | Irwin | Dickerson | Baker | Boxer | Rabinovici | La JoieBlazhenets, GannaGanna Blazhenets, Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, US
81Regional analysis of change in synaptic density over time by cognitive statusDiFilippo | Mcvea | Mclachlan | Pasquesi | Davenport-Sis | Jonaitis | Ennis | Betthauser | Engle | Johnson | Bendlin | ChristianDiFilippo, AlexandraAlexandra DiFilippo, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, US
82Regional tau profiles in early tau pathology populationsKotari | Morris | Svaldi | Southekal | Lu | Pontecorvo | Collins | Shcherbinin | Neuroimaging InitiativeKotari, VikasVikas Kotari, Eli Lilly and Company, Indianapolis, IN, US
83[18F]MK-6240 tau-PET in an Aβ-enriched sample from the 1946 British birth cohort - Insight 46Coath | Markiewicz | Modat | Scott | Malone | Thomas | Dickson | Schöll | Ourselin | Richards | Fox | Cash | SchottCoath, WilliamWilliam Coath, Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, GB
84Longitudinal trajectories of depressive symptoms and regional amyloid accumulation (PiB PET) in clinically normal older adultsMunro | Farrell | Hanseeuw | Buckley | Properzi | Vannini | Amariglio | Quiroz | Blacker | Rentz | Sperling | Johnson | Marshall | GatchelMunro, CatherineCatherine Munro, Brigham and Women's Hospital, Boston, MA, US
85Improving sub-threshold PiB fidelity using relative radioligand deliveryProperzi | Shirzadi | Buckley | Klinger | Hanseeuw | Amariglio | Rentz | Farrell | Price | Chhatwal | Marshall | Gatchel | Johnson | Sperling | SchultzProperzi, MichaelMichael Properzi, Massachusetts General Hospital, Boston, MA, US
86Improved prediction of preclinical cognitive decline using amyloid PET spatial extentFarrell | Thibault | Becker | Price | Hanseeuw | Buckley | Papp | Jacobs | Rentz | Sperling | JohnsonFarrell, Michelle E.Michelle E. Farrell, Massachusetts General Hospital, Harvard Medical School, Boston, MA, US
8718F-MK-6240 Tau PET as a Potential Biomarker for Chronic Traumatic EncephalopathyAlosco | Mundada | La Joie | Asken | Nowinski | Smith | Culhane | Shankar | Amuiri | Pettway | Iaccarino | Windon | Tripodis | Mercier | Kowall | Stein | Grinberg | McKee | Stern | Miller | Mez | Killiany | RabinoviciAlosco, MichaelMichael Alosco, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, US
88Psychosis and tau burden across the AD continuumJohnson* | Ziaggi* | Huey, MD | Kreisl, MD | Talmasov, MD | Lao, PhDJohnson, Aubrey S.Aubrey Johnson, Columbia University Irving Medical Center
89Classifying cognitive resilience to differing levels of Alzheimer’s disease pathologyBoyle | Townsend | Klinger | Coughlan | Hanseeuw | Yang | Amariglio | Farrell | Jacobs | Shirzadi | Yau | Price | Chhatwal | Schultz | Hohman | Donohue | Properzi | Rentz | Johnson | Sperling | BuckleyBoyle, RoryRory Boyle, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, US
90Cerebrospinal fluid neurofilament light predicts increased amyloid, tau, and decreased grey matter densityManchella | Logan | Dage | Hammers | Nemes | Kostadinova | Eloyan | Mundada | La Joie | Iaccarino | Fagan | Foroud | Zetterberg | Koeppe | Aisen | Carrillo | Rabinovici | Dickerson | ApostolovaManchella, MohitMohit Manchella, Indiana University School of Medicine, Indianapolis, IN, US
91Unhealthy white matter connectivity in African American and non-Hispanic white older adultsRoyse | Snitz | Hengenius | Huppert | Roush | Cisneros | Potopenko | Becker | Cohen | ShaabanRoyse, SarahSarah Royse, Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, US
92Locus coeruleus integrity as neural substrate providing resilience against cognitive decline in the face of Alzheimer’s disease pathologyJacobs | Papp | Buckley | Riphagen | Hanseeuw | Boyle | Donovan | Rentz | Sperling | JohnsonJacobs, Heidi ILHeidi IL Jacobs, Massachusetts General Hospital, Gordon Center for Medical Imaging, Boston, MA, US
93Lower locus coeruleus integrity predicts diminished practice effects in cognitively normal older individualsSmegal | Schneider | Jutten | Rentz | Johnson | Sperling | Papp | JacobsSmegal, LindsayLindsay Smegal, Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital/ Harvard Medical School, Boston, MA, US
94PET-based Braak staging predicts neuropsychiatric burden in the Alzheimer’s disease continuumMacedo | Tissot | Therriault | Servaes | Rahmouni | Fernandez-Arias | Z. Lussier | Stevenson | Wang | Quispialaya Socualaya | Nazneen | Ali Hosseini | Kunach | Haeger | Stevenson | Vitali | A. Pascoal | Rosa-NetoC. Macedo, ArthurArthur C. Macedo, McGill University, Montreal, QC, CA
95A computational model to study the combined effect of neuronal connectivity loss and tauopathy progressionRahimabadi | Soucy | BenaliRahimabadi, ArsalanArsalan Rahimabadi, PERFORM Centre, Concordia University, Montreal, QC, CA
96Simulated dose reduction in longitudinal [18F]MK-6240 PETMcLachlan | McVea | DiFilippo | Schöll | Betthauser | Johnson | ChristianMcLachlan, MaxMax McLachlan, Department of Medical Physics, University of Wisconsin – Madison, School of Medicine and Public Health, Madison, WI, US
97Regional amyloid change improves prediction of future tau progression over global metricsThibault | Farrell | Properzi | Mayblyum | Hanseewu | Healy | Price | Becker | Sperling | JohnsonThibault, EmmaEmma Thibault, Massachusetts General Hospital, Boston, MA, US
99Rates of tau PET accumulation along the amyloid timeline in Alzheimer’s diseaseCody | Langhough | Christian | Betthauser | JohnsonCody, KarlyKarly Cody, Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, Madison, WI, US
100Body mass index, pathological tau, and cognition in preclinical AD: Could women with high BMI be protected?Wang | Sundermann | Buckley | Reas | McEvoy | BanksWang, XinXin Wang, Department of Neurosciences, University of California, San Diego., La Jolla, CA, US
101Amyloid drives later tau accumulation for fast progressors in early Braak stagesServaes | Therriault | Tissot | Lussier | Bezgin | Wang | Stevenson | Rahmouni | Stevenson | Pallen | Kunach | Fernandez Arias | Cassa Macedo | Hosseini | Pascoal | Gauthier | Rosa-NetoServaes, StijnStijn Servaes, Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, Montreal, QC, CA
102Brain-wide and AD-risk genetic expression: A descriptive studyHobbs | McCullough | Millar | GordonHobbs, DianaDiana Hobbs, Washington University in St. Louis, St. Louis, MO, US
103Behavioral brain networks underlying the effect of Alzheimer’s pathology on cognitionZiontz | Harrison | JagustZiontz, JacobJacob Ziontz, Helen Wills Neuroscience Institute, University of California Berkeley,, Berkeley, CA, US
104Exploration of 18F-Florzolotau tau PET distribution patterns using machine learning approach in ADHuang | Lee | Lin | Huang | Hsu | Chang | Huang | HsiaoHuang, Shao-YiShao-Yi Huang, Medical Imaging & Radiological Sciences and Healthy Aging Research Center, Chang Gung University, Taoyuan, TW
105The interplay of vascular disease, peripheral interleukin-6, beta-amyloid, and memory in older adultsRizvi | Adams | Sathishkumar | Kim | Larson | McMillan | Brickman | Mapstone | Thomas | Greenia | Corrada | Kawas | YassaRizvi, BatoolBatool Rizvi, University of California, Irvine, Irvine, CA, US
106Gut microbiome composition is associated with cortical amyloid burden in a preclinical human cohortHeston | González | Betthauser | Johnson | Asthana | Knight | Kaddurah-Daouk | Rey | BendlinHeston, MargoMargo Heston, Wisconsin Alzheimer's Disease Research Center, Madison, WI, US
107Study on MR-free template-based spatial normalization for Tau PET Image Quantitation using 18F-FlorzolotauLee | Huang | Lin | Huang | Huang | Wu | Chang | HsiaoLee, Zih-NingZih-Ning Lee, Medical Imaging & Radiological Sciences and Healthy Aging Research Center, Chang Gung University, Taoyuan, TW
108β-Amyloid in World Trade Center responders: Result indicate age-related toxic encephalopathy mediated by an immunogenic amyloid responseClouston | Vaska | Huang | Kritikos | ZhouClouston, SeanSean Clouston, Stony Brook University, Stony Brook, NY, US
109[18F]MK-6240 PET/MRI Test-Retest performance in cognitively normal elderly subjectsLois | Fanglu Fu | Salvatore | Huell | Izquierdo Garcia | Garimella | Dickerson | Johnson | Catana | PriceLois, CristinaCristina Lois, Gordon Center for Medical Imaging, Massachusetts General Hospital, Boston, MA, US

HAI Past Poster Sessions